| Medtronic plc | $111.0b | $91.63 | -1.2% | 1.5M | |
| Edwards Lifesciences Corp | $49.6b | $90.17 | -0.5% | 391.3K | |
| Alcon Inc. Ordinary Shares | $33.6b | $73.06 | -0.9% | 396.7K | |
| Biogen Inc. Common Stock | $30.0b | $221.97 | +1.6% | 149.2K | |
| Zimmer Biomet Holdings, Inc. | $18.8b | $99.79 | -1.0% | 285.9K | |
| Glaukos Corporation | $9.8b | $182.36 | -1.9% | 155.9K | |
| Bausch + Lomb Corporation | $6.0b | $17.16 | -0.8% | 117.7K | |
| Denali Therapeutics Inc. Common Stock | $3.7b | $25.16 | +4.0% | 242.9K | |
| Bioventus Inc. Class A Common Stock | $0.9b | $13.79 | -1.7% | 151.7K | |
| Anteris Technologies Global Corp. Common Stock | $0.8b | $8.81 | +1.0% | 68.6K | |
| BioAge Labs, Inc. Common Stock | $401.9m | $9.75 | +5.3% | 122.2K | |
| AC Immune SA | $222.9m | $2.91 | +2.1% | 76.4K | |
| Alpha Cognition Inc. Common Stock | $180.3m | $9.60 | 0.0% | 41.1K | |
| Outlook Therapeutics, Inc. Common Stock | $170.7m | $0.66 | +9.3% | 6.4M | |
| Alector, Inc. Common Stock | $167.6m | $2.38 | +3.7% | 163.8K | |
| LENZ Therapeutics, Inc. Common Stock | $166.2m | $4.79 | +3.9% | 235.7K | |
| Acumen Pharmaceuticals, Inc. Common Stock | $155.3m | $3.15 | +2.6% | 89.3K | |
| Telomir Pharmaceuticals, Inc. Common Stock | $85.3m | $1.18 | 0.0% | 9.2K | |
| Cognition Therapeutics, Inc. Common Stock | $79.6m | $1.02 | +4.1% | 209.3K | |
| Annovis Bio, Inc. | $74.4m | $1.81 | +3.7% | 132.3K | |
| Envoy Medical, Inc. Class A Common Stock | $51.7m | $0.73 | 0.0% | 23.7K | |
| Greenland Mines Ltd. Common Stock | $29.2m | $10.66 | +27.5% | 1.9M | |
| CervoMed Inc. Common Stock | $23.9m | $2.65 | +1.1% | 109.4K | |
| Longeveron Inc. Common Stock | $22.2m | $0.69 | -16.4% | 823.4K | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $16.9m | $0.39 | 0.0% | 118.8K | |
| OSR Health, Inc. Common Stock | $15.7m | $0.12 | -16.0% | 4.6M | |
| Alzamend Neuro, Inc. Common Stock | $6.3m | $1.60 | 0.0% | 20.0K | |
| 20/20 Biolabs, Inc. Common Stock | $5.2m | $0.53 | 0.0% | 18.0K | |
| HCW Biologics Inc. Common Stock | $5.1m | $2.46 | +13.9% | 240.0K | |
| FibroBiologics, Inc. Common Stock | $4.3m | $1.40 | 0.0% | 100.4K |